Edition:
India

People: Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

203.38USD
1:30am IST
Change (% chg)

$3.13 (+1.56%)
Prev Close
$200.25
Open
$201.61
Day's High
$203.58
Day's Low
$199.60
Volume
58,042
Avg. Vol
66,115
52-wk High
$217.11
52-wk Low
$132.75

Keegan, Joseph 

Dr. Joseph D. Keegan, Ph.D., is Director of the Company. Keegan has held leadership positions in several life science tools and diagnostics companies, including Molecular Devices, Becton Dickinson and Leica, and most recently as President and CEO of ForteBio, Inc. until its sale to Pall Corporation in 2012. Since 2012, Kegan has been a director and advisor for a number of life science tools companies, including publicly-traded Interpace Diagnostics and a several private company boards.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Baumgartner

298,567

Charles Kummeth

9,076,890

James Hippel

2,226,770

Brenda Furlow

754,004

David Eansor

1,347,200

Robert Gavin

1,215,240
As Of  30 Jun 2017